The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.1M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 698K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

4 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Rational design of inhibitors of the bacterial cell wall synthetic enzyme GlmU using virtual screening and lead-hopping.EBI
Astrazeneca
Identification and optimization of Escherichia coli GlmU inhibitors: an in silico approach with validation thereof.EBI
Csir-Indian Institute of Integrative Medicine
High-throughput screening identifies novel inhibitors of the acetyltransferase activity of Escherichia coli GlmU.EBI
Mcmaster University
In vitro validation of acetyltransferase activity of GlmU as an antibacterial target in Haemophilus influenzae.BDB
Astrazeneca